Authors
Latest:
Emerging from the Shadows of Hepatitis CFrom the bright lights of Broadway to the darkness of hepatitis C infection, effective new drugs help patient start life anew.
Latest:
Psoriasis and Psoriatic Arthritis Patient Care: What Pharmacists Should KnowThis activity is supported by educational grants from AbbVie Inc and LEO Pharma Inc.
Latest:
Utilizing Pharmacogenomics Information to Guide AML TreatmentThere are specific treatment options patients may qualify for depending on the cytogenetic or molecular abnormality detected.
Latest:
Diabetes Quality Measurement: A Primer for PharmacistsThe continuing education article reviews diabetes quality improvement efforts and the potential for expanding the role of pharmacists as clinical care providers.
Latest:
3 Tips for Launching a Peer Mentoring ProgramThe first days of pharmacy school can be exciting for students because they are embarking on a new chapter of their lives.
Latest:
Your Auto Insurance Questions About "Pay-as-you-go" AnsweredPay-as-you-go coverage is the latest trend in the auto insurance industry -- but does it really save drivers any money?
Latest:
Out-of-Pocket Healthcare Expenditures and Caps in Patients With Chronic ConditionsA small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.
Latest:
Changing the Conversation: Flip the Script on NaloxoneProviding education and naloxone to those at risk of witnessing or experiencing an overdose is associated with a 30%-45% decrease in overdose death rates, opioid consumption, and emergency visits.
Latest:
Managing Hematologic Cancer Therapies and Reducing COVID-19 RiskIn this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.
Latest:
Growth Hormone Therapy: A Specialty Pharmacy OverviewGrowth hormone deficiency in children and adults is a disease state that utilizes growth hormone therapy. Here is what specialty pharmacists can do for these patients and what they should know about these conditions.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
Diabetic Foot CarePatient education and understanding the relationship between hyperglycemia, peripheral vascular disease, neuropathy, and foot complications are essential to reduce the potential for foot injury, ulceration, or amputation.
Latest:
Accountable Care Organizations: Pharmacy on the Front LinesSpecialty pharmacy is at the forefront of providing the team-based care and patient counseling now being sought in the developing accountable care organization model.
Latest:
Celebrating 45 Years of Pharmacy StampsThis month marks the 45th anniversary of the introduction of the pharmacy stamp. A collector of the commemorative envelopes of first-day covers ruminates on his hobby.
Latest:
Analyzing the Impact of Different Value-Based Insurance Design ProgramsTotal 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
Latest:
Postsurgical Pain ControlData from large survey reports suggest that more than 80% of Americans who undergo surgery experience some level of postsurgical pain.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
Value Based Contracts for Specialty PharmacyIn an era of high-priced drugs, health care stakeholders continue to explore alternative pricing models that focus on the concept of value-based drug purchasing models.
Latest:
Oncology Therapy Choices Under Greater Scrutiny From PayersThe cost of oncology treatment is high and rising in the United States.
Latest:
Top 200 Drugs of 2010This close look at the top 200 drugs of 2010 by sales and prescriptions dispensed reveals the story of a pharmaceutical market in flux.
Latest:
Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells YouDiscontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Latest:
Detecting Signs of Opioid Abuse and Treating the AddictionKnowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.
Latest:
Medication Reconciliation: 2013 and BeyondThe entrepreneurial pharmacist has the responsibility of creating the value proposition for providing medication reconciliation.
Latest:
Statement by Ralph G. Neas, President and CEO, GPhA, Regarding 21st Century CuresGPhA commends House Energy and Commerce Committee Chairman Fred Upton, Ranking Member Frank Pallone, Rep. Diana DeGette, Health Subcommittee Chair Joe Pitts, and Health Subcommittee Ranking Member Gene Green for their bipartisan leadership around fostering the development of new cures.
